J. Thistlethwaite to Antigens, Differentiation, T-Lymphocyte
This is a "connection" page, showing publications J. Thistlethwaite has written about Antigens, Differentiation, T-Lymphocyte.
Connection Strength
0.124
-
Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody. J Immunol. 1992 Jun 01; 148(11):3461-8.
Score: 0.025
-
Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies. Transplantation. 1991 Aug; 52(2):361-8.
Score: 0.024
-
T-cell activation and lymphokine production induced by antihuman CD3 monoclonal antibodies. Transplant Proc. 1991 Feb; 23(1 Pt 1):81-2.
Score: 0.023
-
Activation of human T cells in vivo following treatment of transplant recipients with OKT3. Transplantation. 1990 Oct; 50(4):608-12.
Score: 0.022
-
The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine. Transplant Proc. 1987 Feb; 19(1 Pt 3):1901-4.
Score: 0.017
-
Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules. J Immunol. 1994 Aug 01; 153(3):1054-67.
Score: 0.007
-
OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release. Transplantation. 1991 Aug; 52(2):354-60.
Score: 0.006